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Pulmonary embolism in the therapeutic practice, risk 
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Abstract 
Pulmonary embolism (PE) is a “great imitator” and the symptoms of the disease are nonspecific, besides 
there is a lack of alertness of doctors and patients in terms of the development of this terrible 
complication. The aim of our work is to assess the risk of PE developing in patients of the therapeutic 
profile, to identify patients at high risk for determining direct sources of thrombosis and to analyze the 
most significant factors that can lead to errors in the diagnosis of PE on the example of a clinical case 
with an unfavorable outcome. 
Totally 78 patients were examined. A study of hospitalized patients with a therapeutic profile using the 
Geneva and Wells scales revealed a high risk of PE in 6,4% of cases. In the high-risk group with the help 
of additional survey methods, there was a direct threat of PE development and in two cases PE of small 
branches was confirmed. 
Analyzing one clinical case it is worth to remark such reasons for the late diagnosis of PE and an 
unfavorable outcome as acute leg injury and the presence of DVT, low compliance with the patient, lack 
of alertness in PE development during hospitalization, unpredictable case anamnesis, reassessment of 
additional studies (CT) conclusion, late appointment of methods for diagnosing of the localization and 
massiveness of PE. 
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Introduction 
Nowadays pulmonary thromboembolism (PE) is one of the most common cardiovascular 
pathologies and averages from 0.5 to 2 cases per 1000 per year [5]. The incidence of PE is 
between 23 and 250 cases per 100000 per year, but every second case is not diagnosed [3]. This 
is due primarily to the fact that PE is a “great imitator” and the symptoms of the disease are 
nonspecific, besides there is a lack of alertness of doctors and patients in terms of the 
development of this terrible complication. PE is the second most common cause of sudden 
death [6]. In recent years mortality from PE has increased significantly and amounts 117 cases 
per 100000. Moreover, in 70% of cases the diagnosis of PE has been already put posthumously 
[7]. 
The main predisposing factors for the development of PE are thrombosis of the deep veins of 
the lower extremities, but in therapeutic practice this often remains beyond the attention of the 
physician. However, it should be remembered that such clinical manifestations as central 
venous catheterization, chronic cardiac and respiratory insufficiency, sepsis, malignant 
neoplasms, chemo- and hormone therapy, thrombophilia are among the factors of moderate 
risk, and pregnancy, postpartum status, advanced age, obesity, varicose veins, prolonged bed 
rest (more than 3 days) and prolonged sitting position are factors of low risk [4]. 
Modern laboratory tests allow to identify hereditary factors of PE development: resistance to 
activated protein C (the presence of this mutation increases the probability of occurrence of 
deep vein thrombosis in 3 times); mutation of 20210A prothrombin (the probability of 
developing deep vein thrombosis or PE increases by 2 times) [2]. 
The aim of our work is to assess the risk of PE developing in patients of the therapeutic 
profile, to identify patients at high risk for determining direct sources of thrombosis and to 
analyze the most significant factors that can lead to errors in the diagnosis of PE on the 
example of a clinical case with an unfavorable outcome. 
The work was carried out in the therapeutic, pulmonological and cardiological departments of 
the city clinical hospital. Standard clinical examination methods, laboratory tests: general 
blood test, coagulogram, renal and liver tests were done for patients. A modified Geneva scale 
[9] and a Wells scale [11] with a three-level probability assessment scheme were used to  
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assess the risk of PE. Since the use of the Geneva scale made 
it possible to identify intermediate and high degrees of 
probability in a larger number of patients, it is important to 
focus on its results. 
Totally 78 patients were examined: 37 men (47%) and 41 
women (53%). From them 25 patients (32%) have 
cardiovascular diseases, 20 patients (25%) have 
bronchopulmonary system, 4 patients (5%) with oncological 
pathology, 2 patients (3%) with liver diseases, 27 patients 
(35%) had several comorbid pathology. 
According to the scales, most patients had intermediate risk of 
PE (Graph. 1). 
 
 
 
Graph 1: PE risk distribution in hospitalized patients according to 
Geneva and Wells scale. 
 
In the group with a high probability of PE developing (5 
patients), women (3 person) predominated; cardiovascular 
diseases dominated (4 person). Additional examination of the 
lower extremities vessels revealed thrombosis of the deep 
veins in 3 patients, which was 60% among group of high PE 
risk. In 2 patients of this group the history and clinical signs 
allowed to suspect PE of the small branches, which was 
confirmed by an additional examination (computed 
tomography (CT) angiography, echocardiography (EchoCG), 
while the coagulogram was absolutely not informative. 
Thus, a study of hospitalized patients with a therapeutic 
profile using the Geneva and Wells scales revealed a high risk 
of PE in 6,4% of cases. In the high-risk group with the help of 
additional survey methods, there was a direct threat of PE 
development and in two cases PE of small branches was 
confirmed. 
However, the lack of clinical alertness can lead to late 
diagnosis and to adverse outcomes of the disease. On the 
example of the analysis of the clinical case on the basis of the 
pulmonology department, it is possible to identify the main 
factors that led to late diagnosis and irreversible 
consequences. 
Patient M., 43 years old, complained of profuse hemoptysis, 
shortness of breath at minimal load, pain in the left half of the 
chest, subfebrile temperature. He connected the disease s with 
a hypothermia on fishing 1,5 month ago, after which there 
was a sore throat and a rhinitis. Shortness of breath appeared a 
month ago, and three days ago sharply increased. X-ray 
revealed infiltrative changes on the left with destruction 
(Graph.2). 
 
 
 
Graph 2: Frontal chest X-ray of the patient M. during 
hospitalization. 
 
The left-sided destructive pneumonia was diagnosed, was 
intravenous antibacterial therapy (ceftriaxone + levofloxacin) 
was prescribed. But in7 days patient had the negative clinical 
dynamics. Chest CT scan was performed, the conclusion of 
which was destructive pneumonia on the left. 
The duration of the disease, sudden development of dyspnea, 
the presence of hemoptysis and chest pain, negative clinical 
dynamics and the absence of the effect of antibiotic therapy 
led to the need to differentiate the disease from PE. Correct 
collection of anamnesis in patients allows including PE in the 
list of neologies requiring differential diagnosis. 
However the patient denied all possible causes of thrombosis. 
Clinical indices are distinguished by large polymorphism: 
dyspnea, tachypnea, chest pain, cough, hemoptysis, syncope, 
syndromes of deep venous thrombosis (DVT), cyanosis, 
tachycardia, fever (their specificity varies within 7-68%) [1]. 
The indicator of D-dimer level, although highly sensitive and 
fast in determination, but not specific, can only exclude PE (in 
the case of a concentration <0,5 mg/L of its level) [10]. 
In this case the study of this marker was not appropriate 
because of profuse hemoptysis. Suddenly on the tenth day the 
patient's condition deteriorated seriously: blood pressure was 
60/40 mm Hg, oxygen saturation was 78%, heart rate was 128 
per min, breathing rate was 38 per min. The patient was 
transferred to the intensive care unit (ICU). Radiographically 
he had the negative dynamics (Graph. 3). There was a second 
suspicion of a possible PE (relapse). 
 
 
 
Graph 3: Frontal chest X-ray of the patient M. on the 10th day after 
hospitalization. 
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In the acute stage of PE, electrocardiogram (ECG) and 
echoCG should be performed [8]. According to the ECG the 
patient had blockade of the posterior branch of the right leg of 
the fasciculus of the bundle, sinus tachycardia, negative T 
teeth in V1-V3, which indicated an overload of the right heart. 
With the purpose of excluding PE, a repeated chest CT with 
angiography was assigned: multiple defects of filling in the 
vessels of the right lung, almost complete absence of passage 
of the contrast in the pulmonary trunk, destruction of the 
parenchyma of the left lung were diagnosed (Graph. 4). 
 
  
 
Graph 4: Chest CT-angiogram of the patient M. on the 12th day after hospitalization. 
 
Multilayer angio-CT is a minimally invasive and relatively 
accessible method that allows confirming or excluding the 
diagnosis of PE [9]. In case of timely establishment of the 
correct diagnosis and prescribing of adequate therapy, it is 
possible to minimize the risk of death from PE to 8% [2]. 
The diagnosis of PE was put on the 12th day of 
hospitalization, when the prognosis for the patient's life was 
already unfavorable. After the diagnosis, the patient 
remembered a left leg injury 4 months before the first episode 
of shortness of breath. At that time the patient was consulted 
by a traumatologist, DVT of the left tibia was revealed, and 
doctor recommended compression stockings and long-term 
using of rivaroxoban 20 mg per day, but the patient did not 
perform this. 
The patient died in the ICU in 2 weeks after hospitalization. 
There was a coincidence of clinical and pathological-
anatomical diagnoses: 
Recurrent PE, multiple right-sided infarct-pneumonia, 
thrombosis and complete occlusion of the left pulmonary 
artery (Graph. 5), secondary pulmonary hypertension, right 
ventricular hypertrophy, dilatation of the right ventricular and 
atrium, decay cavity with suppuration on the left side, lung 
and heart failure, hyperemia and hypertrophy of the liver, 
dystrophic changes in the kidneys. 
 
 
   
 
Graph 5: Autopsy data of the lungs in patient M. 
 
Analyzing this clinical case it is worth to remark such reasons 
for the late diagnosis of PE and an unfavorable outcome as 
acute leg injury and the presence of DVT, low compliance 
with the patient, lack of alertness in PE development during 
hospitalization, unpredictable case anamnesis, reassessment 
of additional studies (CT) conclusion, late appointment of 
methods for diagnosing of the localization and massiveness of 
PE. 
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